Helicobacter Pylori Infection among Children with Chronic Liver Diseases

Document Type : Original Article

Authors

1 Professor of Pediatric Hepatology, Gastroenterology and Nutrition Department, National liver Institute, Menoufia University, Shebin El-koom, Egypt.

2 Assistant Professor of Pediatric Hepatology, Gastroenterology and Nutrition Department, National liver Institute, Menoufia University, Shebin El-koom, Egypt.

3 Professor of Clinical and Molecular Microbiology & Immunology Department, National liver Institute, Menoufia University, Shebin El-koom, Egypt.

4 Resident of Pediatric Hepatology, Gastroenterology and Nutrition Department, National liver Institute, Menoufia University, Shebin El-koom, Egypt.

5 Lecturer of Pathology Department, National Liver Institute, Menoufia University, Shebin El-koom, Egypt.

Abstract

Background: Helicobacter pylori (H.pylori) infection is a gastrointestinal pathogen with emerging evidence linking it to chronic liver diseases (CLD).  Aim: To investigate the prevalence of H. pylori infection among children with CLD, its endoscopic and histopathological associations, and its effect on disease severity and severity of bleeding. Methods: This cross-sectional study included 63 children diagnosed with CLD at the National Liver Institute, Menoufia University, Egypt. Patients were categorized into H. pylori-positive and H. pylori-negative groups. All patients underwent gastrointestinal endoscopy, with histopathological examination and H. pylori stool antigen in stools. Demographic, clinical, laboratory, endoscopic, and histopathological findings were analyzed. Results: H. pylori-positive patients showed higher prevalence of abdominal pain, dyspepsia, anemia, melena, and hematemesis (P < 0.05). H. pylori infection was significantly associated with lower hemoglobin and elevated liver enzymes: ALT (89.3% vs. 62.9%, P = 0.000), AST (75% vs. 37.14%, P = 0.003), and total serum bilirubin (92.86% vs. 51.43%, P < 0.001). Endoscopic findings showed a significant association with gastritis (P = 0.007) and gastric nodularity (P = 0.006) in H. pylori-positive patient. A significantly higher infiltration of inflammatory cells and lymphoid follicle formation in both duodenal and gastric biopsies of H. pylori-positive patients. The need for intervention (sclerotherapy/banding) was significantly higher in H. pylori-positive patients. GBS was not statistically different between the two groups.  Conclusion: H. pylori infection in children with CLD was associated with a higher prevalence of gastritis, gastric nodularity, and increased gastrointestinal bleeding symptoms with increased rates of sclerotherapy/banding in patient with CLD.

Keywords

Main Subjects

References

  1. Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc. 2022;6:185-94.
  2. Spee LA, Madderom MB, Pijpers M, van Leeuwen Y, Berger MY. Association between Helicobacter pylori and gastrointestinal symptoms in children. Pediatr. 2010;125:651-69.
  3. Wang Y-K, Li C, Zhou Y-M, Zeng L, Li Y-Y, Huang S-L, et al. Histopathological features of Helicobacter pylori infection in gastric mucosa. J Inflamm Res. 2022:6231-43.
  4. Chen C, Zhang C, Wang X, Zhang F, Zhang Z, Ma P, et al. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur J Gastroenterol Hepatol. 2020;32:857-66.
  5. Zahmatkeshan M, Matani R, Asadian F. Association between Helicobacter pylori infection and cirrhosis in children. Medical Studies/Studia Medyczne. 2019;35:198-202.
  6. Homan M, Jones NL, Bontems P, Carroll MW, Czinn SJ, Gold BD, et al. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). J Pediatr Gastroenterol Nutr. 2024;79:758-85.
  7. Dore MP, Pes GM. What Is New in Helicobacter pylori Diagnosis. An Overview. J Clin Med. 2021;10:31-54.
  8. Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med. 2015;3:10.
  9. Carmona SG, Viana JCA, Rodríguez EJA, Mesa JA, Cala TLP, Martínez A, et al. Utilidad de la coloración de Giemsa para diagnosticar Helicobacter pylori en pacientes con lesiones preneoplásicas. Rev Colomb Gastroenterol. 2022;37:402-9.
  10. McDiarmid SV, Merion RM, Dykstra DM, Harper AM. Selection of pediatric candidates under the PELD system. Liver Transpl. 2004;10:23-30.
  11. Kamath PS, Kim WR. The model for end‐stage liver disease (MELD). Hepatol. 2007;45:797-9.
  12. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end–stage liver disease. Hepatol. 2001;33:464-70.
  13. Abo Hussein RRM. Role of Endoscopy in Management of Non Variceal Upper Gastrointestinal Bleeding in Pediatrics: Menoufia University; 2022.
  14. Roth-Cline M, Gerson J, Bright P, Lee CS, Nelson RM. Ethical considerations in conducting pediatric research. Clin Med Pediatr: Springer; 2011. p. 219-44.
  15. Lupu A, Miron IC, Cianga AL, Cernomaz AT, Lupu VV, Gavrilovici C, et al. The prevalence of liver cytolysis in children with helicobacter pylori infection. Children. 2022;9:14-98.
  16. Barakat S, Abdel-Fadeel M, Sharaki O, Shafei ME, Elbanna B, Mahfouz A. Is Helicobacter pylori infection a risk factor for non-alcoholic fatty liver disease in children? Eur J Pediatr. 2024;184:1-8.
  17. Casswall TH, Németh A, Nilsson I, Wadström T, Nilsson H-O. Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease. Scand J Gastroenterol. 2010;45:160-7.
  18. Kim HJ, Lim YJ. Endoscopic findings and predictors of gastrointestinal lesions in children with iron deficiency anemia. Pediatr Hematol Oncol J. 2024;41:114-20.
  19. Zou Y-G, Wang H, Li W-W, Dai D-L. Challenges in pediatric inherited/metabolic liver disease: Focus on the disease spectrum, diagnosis and management of relatively common disorders. World J Gastroenterol. 2023;29:21-34.
  20. Xiao Q-Y, Wang R-L, Wu H-J, Kuang W-B, Meng W-W, Cheng Z. Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients. J Multidiscip Healthc. 2024:1127-35.
  21. Ibrahim A, Morais S, Ferro A, Lunet N, Peleteiro B. Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: systematic review and meta-analysis of 244 studies. Dig Liver Dis. 2017;49:742-9.
  22. Lupu A, Miron IC, Cernomaz AT, Gavrilovici C, Lupu VV, Starcea IM, et al. Epidemiological Characteristics of Helicobacter pylori Infection in Children in Northeast Romania. Diagnostics. 2023;13:40-82.
  23. Borka Balas R, Meliț LE, Mărginean CO. Worldwide prevalence and risk factors of Helicobacter pylori infection in children. Children. 2022;9:13-59.
  24. Pornsiripratharn W, Treepongkaruna S, Tangkittithaworn P, Chitrapaz N, Lertudomphonwanit C, Getsuwan S, et al. Prevalence and Associated Factors of Vertebral Fractures in Children with Chronic Liver Disease with and without Liver Transplantation. Pediatr Gastroenterol Hepatol Nutr. 2024;27:158-83.
  25. Dănilă C, Cardos IA, Pop-Crisan A, Marc F, Hoza A, Chirla R, et al. Correlations between Endoscopic and Histopathological Assessment of Helicobacter pylori-Induced Gastric Pathology—A Cross-Sectional Retrospective Study. Life. 2022;12:20-96.
  26. Barakat S, Abdel-Fadeel M, Sharaki O, Shafei ME, Elbanna B, Mahfouz A. Is Helicobacter pylori infection a risk factor for non-alcoholic fatty liver disease in children? Eur J Pediatr. 2025;184:1-8.
  27. Awuku YA, Simpong DL, Alhassan IK, Tuoyire DA, Afaa T, Adu P. Prevalence of helicobacter pylori infection among children living in a rural setting in Sub-Saharan Africa. BMC public health. 2017;17:1-6.
  28. Darko R, Yawson A, Osei V, Owusu-Ansah J, Aluze-Ele S. Changing patterns of the prevalence of Helicobacter pylori among patients at a corporate hospital in Ghana. Ghana Med J. 2015;49:147-53.
  29. Malaty HM, Logan ND, Graham DY, Ramchatesingh JE. Helicobacter pylori infection in preschool and school-aged minority children: effect of socioeconomic indicators and breast-feeding practices. Clin Infect Dis. 2001;32:1387-92.
  30. Jishnu K, Sahu BR, Das M, Nath P, Biswal SR, Mohakud NK, et al. Age-Stratified Prevalence of Helicobacter pylori Infection in Children With Recurrent Abdominal Pain: A Prospective Observational Study. Cureus. 2025;17:32-41.
  31. Attallah AM, Albannan MS, Ghaly MF, Sallam SE, Amer MM, Attia AA. Prevalence of Helicobacter pylori infection in patients with chronic hepatitis C. J Genet Eng & Biotechnol. 2022;20:13-94.
  32. Zhang J, Yuan W, Xing Y, Ma X, Xuan F. Helicobacter pylori infection, clarithromycin-resistant genes and CYP2C19 gene polymorphisms in asymptomatic school-age children in Baigou New Town, Baoding City, Hebei Province. PaK J Med Sci. 2025;41:84-98.
  33. Haghi-Ashtiani MT, Monajemzadeh M, Motamed F, Mahjoub F, Sharifan M, Shahsiah R, et al. Anemia in children with and without Helicobacter pylori infection. Arch Med Res. 2008;39:536-40.
  34. Bolia R, Srivastava A. Ascites and chronic liver disease in children. Indian J Pediatr. 2024;91:270-9.
  35. Kalach N, Gosset P, Dehecq E, Decoster A, Georgel AF, Spyckerelle C, et al. A one-step immune-chromatographic Helicobacter pylori stool antigen test for children was quick, consistent, reliable and specific. Acta Paediatr. 2017;106:2025-30.
  36. Zhou X, Su J, Xu G, Zhang G. Accuracy of stool antigen test for the diagnosis of Helicobacter pylori infection in children: a meta-analysis. Clin Res Hepatol Gastroenterol. 2014;38:29-38.
  37. Miao R, Chen J, Gao S, Wang L, Zhou W, Wan C, et al. A randomised controlled clinical study of standard triple therapy, bismuth-based quadruple therapy and sequential therapy for Helicobacter pylori infection in children. BMC pediatrics. 2024;24:43-52.
  38. Hashim ER, Abufaddan NH, Osman AM, Medhat MA. Helicobacter pylori Infection in Children: An Uphill Climb. Afro-Egyptian Journal of Infectious and Endemic Diseases. 2024;14:1-20.
  39. Van Veen SJ, Levy EI, Huysentruyt K, Vandenplas Y. Clinical dilemmas for the diagnosis and treatment of Helicobacter pylori infection in children: from guideline to practice. Pediatr Gastroenterol Hepatol Nutr. 2024;27:267-90.
  40. Moreno Trigos Y, Tortajada-Girbés M, Simó-Jordá R, Hernández Pérez M, Hortelano I, García-Ferrús M, et al. Use of Deep-Amplicon Sequencing (DAS), Real-Time PCR and In Situ Hybridization to Detect pylori and Other Pathogenic Helicobacter Species in Feces from Children. Diagnostics. 2024;14:12-6.
  41. Organization WH. WHO Housing and Health Guidelines. Geneva, Household crowding. https://www.ncbi.nlm.nih.gov/books/NBK535289/: NCBI; 2018 [Available from: https://www.ncbi.nlm.nih.gov/books/NBK535289/.
Egyptian Journal of Medical Research
Volume 6, Issue 4
October 2025
Pages 96-123

Files

Share

How to cite

Statistics